๊ฑฐ๋ž˜์†Œ
์ค‘์•™ํ™” ๊ฑฐ๋ž˜์†Œ
ํƒˆ์ค‘์•™ํ™” ๊ฑฐ๋ž˜์†Œ

AstraZeneca PLC
AZN
#58

โ‚ฉ222,515.89ย ย 

1.1%

Closed:ย Aug 28, 20:00:00 PM UTC+00:00
โ‚ฉ222,173.98ย ย 

0.15%

ํ”„๋ฆฌ๋งˆ์ผ“:ย Aug 31, 08:31:59 AM UTC+00:00

AstraZeneca PLC Info

์‹œ๊ฐ€์ด์•ก
โ‚ฉ344.56T

0.15%

์ผ๊ฐ„ ๊ฑฐ๋ž˜๋Ÿ‰
โ‚ฉ650.96M
์ฃผ๊ฐ€์ˆ˜์ต๋น„์œจ
113.61
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
1.40%
EPS
โ‚ฉ1.95K
52์ฃผ ๋ฒ”์œ„
โ‚ฉ99.69Kโ‚ฉ290.91K
์›น์‚ฌ์ดํŠธ
์ž์‚ฐ ์œ ํ˜•
์ฃผ์‹
์ง์›
94300
์„ค๋ฆฝ
Apr 6, 1999
์ฃผ ๊ฑฐ๋ž˜์†Œ
Nasdaq
CIK ๋ฒˆํ˜ธ
0000901832

ํ† ํฐํ™”๋œ ์ฃผ์‹ ๋ฐ์ดํ„ฐ

ํ‰๊ท  ํ† ํฐํ™”๋œ ๊ฐ€๊ฒฉ
โ‚ฉ168.59K
๊ฐ€๊ฒฉ ์ฐจ์ด
+โ‚ฉ53.57K(-24.11%)
ํ† ํฐํ™”๋œ ์‹œ์ด
โ‚ฉ208.76M

47.72%

ํ† ํฐํ™”๋œ ๊ฑฐ๋ž˜๋Ÿ‰(24์‹œ๊ฐ„)
โ‚ฉ254.79M

67.06%

๋ฐœํ–‰์ธ
๊ณ„์•ฝ
์ต์Šคํ”Œ๋กœ๋Ÿฌ
AZN USD ๋ณ€ํ™˜๊ธฐ
AZN
KRW
๊ฐ€๊ฒฉ ํผํฌ๋จผ์Šค
๋‚ฎ์Œ
โ‚ฉ221.75K
๋†’์Œ
โ‚ฉ222.63K

๋ฐ์ดํ„ฐ ๋กœ๋”ฉ ์ค‘

์ž ์‹œ๋งŒ ๊ธฐ๋‹ค๋ ค ์ฃผ์„ธ์š”, ์ฐจํŠธ ๋ฐ์ดํ„ฐ๋ฅผ ๋กœ๋”ฉํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค

AstraZeneca PLC ์ปค๋ฎค๋‹ˆํ‹ฐ

skeleton-white
ย 
ย 
ย 
ย 
ย 
ย 

AstraZeneca PLC ์†Œ๊ฐœ

What is AstraZeneca PLC?

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

AstraZeneca PLC ๋ผ์ด๋ธŒ ๊ฐ€๊ฒฉ ๋ฐ์ดํ„ฐ

AstraZeneca PLC์˜ ํ˜„์žฌ ์‹œ์žฅ ๊ฐ€๊ฒฉ์€ โ‚ฉ222,173.98์ด๋ฉฐ 24์‹œ๊ฐ„ ๊ฑฐ๋ž˜๋Ÿ‰์€ โ‚ฉ650.96M์ž…๋‹ˆ๋‹ค. ํ•ด๋‹น ์ž์‚ฐ์˜ ์‹œ๊ฐ€์ด์•ก์€ ์ง€๋‚œ 24์‹œ๊ฐ„ ๋™์•ˆ -0.15% ๋ณ€๋™ํ•œ ํ›„ โ‚ฉ344.56T์ž…๋‹ˆ๋‹ค.

ํ† ํฐํ™”๋œ AstraZeneca PLC์€(๋Š”) โ‚ฉ168,598.22์— ๊ฑฐ๋ž˜๋˜๊ณ  ์žˆ์œผ๋ฉฐ, ํ† ํฐํ™”๋œ ์‹œ๊ฐ€์ด์•ก์€ โ‚ฉ208.76M, 24์‹œ๊ฐ„ ๊ฑฐ๋ž˜๋Ÿ‰์€ โ‚ฉ254.79M์ž…๋‹ˆ๋‹ค. ํ•ด๋‹น ํ† ํฐํ™”๋œ ์ž์‚ฐ์€ ์ง€๋‚œ 24์‹œ๊ฐ„ ๋™์•ˆ 47.73% ๋ณ€๋™ํ–ˆ์Šต๋‹ˆ๋‹ค.